JarnaginK, ChandaS, CoronadoD, et al.Crisaborole topical ointment, 2%: a nonsteroidal, topical, anti-inflammatory phosphodiesterase 4 inhibitor in clinical development for the treatment of atopic dermatitis. J Drugs Dermatol, 2016; 15(4):390–396.
2.
NguyenHL, YianniasJA. Contact dermatitis to medications and skin products. Clin Rev Allergy Immunol, 2019; 56(1):41–59.
3.
SchmutzJL, BarbaudA, TrechotP. Contact allergy with tacrolimus then pimecrolimus. Ann Dermatol Venereol, 2008; 135(1):89.
4.
ZhangAJ, WarshawEM. Allergic contact dermatitis caused by mupirocin and pimecrolimus. Contact Dermatitis, 2019; 80(2):132–133.
